| Symbol | FEED |
|---|---|
| Name | NANOVIBRONIX, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Industrial Specialties |
| Address | 525 EXECUTIVE BOULEVARD, ELMSFORD, New York, 10523, United States |
| Telephone | +1 914 233-3004 |
| Fax | — |
| — | |
| Website | https://www.nanovibronix.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001326706 |
| Description | NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements. Additional info from NASDAQ: |
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
Read moreNew Form DEF 14A - ENvue Medical, Inc. <b>Filed:</b> 2026-07-24 <b>AccNo:</b> 0001493152-26-034623 <b>Size:</b> 288 KB
Read moreENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
Read moreENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
Read moreENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool
Read moreGlibert Christian Michael 🔴 sold 210.0K shares of ENvue Medical, Inc. ($FEED) at $0.69 Transaction Date: Jun 22, 2026 | Filing ID: 000007
Read moreNew Form SCHEDULE 13D/A - ENvue Medical, Inc. <b>Filed:</b> 2026-06-22 <b>AccNo:</b> 0002111050-26-000008 <b>Size:</b> 7 KB
Read moreENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
Read moreENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
Read more